Summary
Medallia has 3 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.
Reviewer brief
As of 17 Sep 2026, Medallia is listed in the FedRAMP registry as FedRAMP Authorized, with authorization issued 09 Apr 2025 and audited by Kratos. As of 17 Sep 2026, Medallia is listed in the CSA STAR registry at Level 1 self-assessment (CAIQ), issued 25 Nov 2019. As of 17 Sep 2026, Medallia is listed in the EU-US Data Privacy Framework registry as Active across EU-US Certification, SW-US Certification, and UK Extension Certification, originally issued 27 Jul 2017 and set to expire 03 Mar 2027. As of 17 Sep 2026, no public evidence found for SOC 2 for Medallia. As of 17 Sep 2026, no public evidence found for HIPAA for Medallia.
- FedRAMP: Authorized (registry-listed), issued 09 Apr 2025, auditor Kratos, as of 17 Sep 2026
- CSA STAR: Level 1 self-assessment (CAIQ), registry-listed, issued 25 Nov 2019, as of 17 Sep 2026
- EU-US Data Privacy Framework: Active (EU-US, SW-US, UK Extension), registry-listed, issued 27 Jul 2017, expires 03 Mar 2027, as of 17 Sep 2026
Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.
Among customer support vendors
3verified rows
Category median 1, across 63 indexed customer support vendors. Medallia has more verified rows than 100 percent of them.
ai-analyticscustomer-experiencefeedback-managementsentiment-analysis
Compare with similar vendors
Pick your own comparisonCompliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this. Check the vendor trust centre.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the Customer support category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.
